Hubei Biocause Pharmaceutical Co., Ltd. (SHE:000627)

China flag China · Delayed Price · Currency is CNY
1.750
-0.060 (-3.31%)
Jul 18, 2025, 2:45 PM CST
2.34%
Market Cap8.48B
Revenue (ttm)40.70B
Net Income (ttm)-771.87M
Shares Out4.90B
EPS (ttm)-0.15
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume452,404,527
Average Volume24,527,962
Open2.230
Previous Close1.810
Day's Range1.720 - 2.230
52-Week Range1.650 - 5.420
Beta0.78
RSI0.93
Earnings DateAug 29, 2025

About SHE:000627

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. It exports its products to approximately 85 countries, including the United States, the European Union, and inter... [Read more]

Sector Financials
CEO Wenxia Zhou
Employees 1,765
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000627
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.